Colinz Laboratories Ltd.
BSE: 531210 | Sector: Health care |
NSE: N.A. | ISIN Code: INE923C01011 |
BSE 09:39 | 30 Jun | 25.00 |
-0.15 (-0.60%) |
OPEN
26.40 |
HIGH
26.40 |
LOW
25.00 |
NSE 05:30 | 01 Jan | Colinz Laboratories Ltd |
OPEN | 26.40 |
PREVIOUS CLOSE | 25.15 |
VOLUME | 240 |
52-Week high | 43.45 |
52-Week low | 15.55 |
P/E | 33.78 |
Mkt Cap.(Rs cr) | 11 |
Buy Price | 24.05 |
Buy Qty | 54.00 |
Sell Price | 26.40 |
Sell Qty | 776.00 |
Colinz Laboratories Ltd. (COLINZLABS) - Market Capital
Market Cap
COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
Sun Pharma.Inds. | 838.50 | 0.04 | 966.90 | 664.10 | 201181.30 |
Divi's Lab. | 3556.00 | -0.80 | 5425.00 | 3365.10 | 94394.02 |
Cipla | 926.50 | -2.02 | 1083.15 | 850.00 | 74759.29 |
Dr Reddy's Labs | 4365.70 | 0.06 | 5613.65 | 3655.00 | 72662.71 |
Apollo Hospitals | 3714.05 | -0.03 | 5930.70 | 3365.90 | 53400.61 |
Torrent Pharma. | 2864.60 | 0.86 | 3304.45 | 2485.00 | 48474.76 |
Gland Pharma | 2679.55 | 1.03 | 4350.00 | 2498.00 | 44132.19 |
Abbott India | 18820.60 | -0.76 | 23902.30 | 15525.00 | 39993.77 |
Piramal Enterp. | 1665.95 | 0.17 | 3013.00 | 1561.00 | 39757.90 |
Biocon | 311.60 | 0.42 | 414.30 | 308.25 | 37410.70 |
Zydus Lifesci. | 356.55 | 0.14 | 655.00 | 319.40 | 36500.02 |
Max Healthcare | 370.25 | 0.64 | 472.60 | 251.00 | 35900.55 |
Alkem Lab | 2995.55 | 0.76 | 4067.70 | 2835.00 | 35811.80 |
Aurobindo Pharma | 513.80 | -0.20 | 1012.90 | 503.40 | 30103.54 |
Lupin | 612.95 | -1.17 | 1193.00 | 583.05 | 27864.71 |
Glaxosmi. Pharma | 1497.10 | -0.05 | 1917.00 | 1433.05 | 25362.37 |
Laurus Labs | 467.40 | 0.17 | 723.55 | 433.20 | 25115.74 |
Ipca Labs. | 903.65 | 0.81 | 1383.55 | 831.40 | 22925.60 |
Syngene Intl. | 560.60 | -0.17 | 699.95 | 508.10 | 22504.17 |
Pfizer | 4089.55 | -0.04 | 6164.80 | 4056.00 | 18709.69 |
Quick Links for Colinz Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices